<DOC>
	<DOCNO>NCT02596581</DOCNO>
	<brief_summary>The aim present study determine gingival crevicular fluid ( GCF ) chemerin interleukin-6 ( IL-6 ) level analyse relationship chemerin IL-6 periodontal health chronic periodontitis ( CP ) without type 2 diabetes mellitus ( T2DM ) well evaluate effect non-surgical periodontal therapy GCF chemerin level .</brief_summary>
	<brief_title>Chemerin IL-6 Levels Diabetes Periodontitis</brief_title>
	<detailed_description>Adipose tissue active endocrine organ secrete several inflammatory cytokine , namely , adipokines , interfere insulin sensitivity , glucose lipid metabolism , inflammatory process.Chemerin , recently identify adipose tissue specific adipokine , crucial role adipocyte differentiation development , well glucose , lipid metabolism inflammation . Experimental data support pro- anti-inflammatory role chemerin immune cell . Therefore , clear whether chemerin contributes progression inflammation resolution.The present investigation devote elucidate role chemerin pathogenesis might link DM periodontal disease . We hypothesize chemerin may hold value inflammatory mediator CP patient without T2DM non-surgical periodontal treatment could beneficial influence level chemerin . The aim study : 1. determine role chemerin pathogenesis periodontal disease DM via compare GCF level IL-6 , know proinflammatory effect periodontal disease DM 2. evaluate effect non-surgical periodontal treatment GCF chemerin level periodontitis patient without T2DM . The study include eighty subject : 20 subject systemically periodontally healthy ( CTRL group ) , 20 patient T2DM periodontally healthy ( DM-CTRL group ) , 20 patient systemically healthy CP ( CP group ) , 20 patient CP T2DM ( DM-CP group ) . Periodontitis patient receive nonsurgical periodontal therapy . GCF sample clinical periodontal parameter assess baseline 6 week periodontal therapy . Chemerin interleukin-6 ( IL-6 ) level measure enzyme-linked immunosorbent assay , relative ratio calculate . Subjects clinically evaluate use follow parameter ; plaque index ( PI ) , gingival index ( GI ) , PD , clinical attachment level ( CAL ) BOP ( deem positive occur within 15 second probe ) . Clinical measurement record one calibrated examiner six site per tooth full-mouth teeth exclude third molar use Williams periodontal probe ( Nordent Manufacturing Inc. , ElkGrove Village , IL , USA ) calibrate millimeter . Anthropometric measurement include weight ( kg ) height ( ) subject calculate BMI ( weight divide square height , kg/m2 ) . All clinical radiological examination , sample site selection perform one examiner sample collect day clinical examination patient . This prevent contamination GCF blood associate probe inflame site . The deep two pocket site single-rooted teeth select collection GCF periodontitis group , also two pocket site absence inflammation sample ensure collection adequate amount GCF control group . In patient CP DM-CP group , site show great PD measure periodontal probe sign inflammation , along radiographic conformation bone loss sample . GCF sample collect baseline 8 week baseline sample periodontitis group , baseline control group . To avoid salivary contamination , sit sample rinsed water , isolated cotton roll gently air dry . Paper strip ( Periopaper ; Oraflow Inc. , Smithtown , NY , USA ) gently insert 1-2 mm sulcus/pocket 30 second . Care take avoid mechanical injury gingival tissue . All sample contain blood saliva discard . The two strip two site individual place cod seal plastic eppendorf tube pool freeze -80 degree</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<criteria>Diabetic subject T2DM know systemic disease T2DM Subjects HbA1c level &lt; 8 % ≥ 6.5 % ( well moderate control ) Chronic periodontitis patient radiographic evidence bone loss attachment loss minimum 6 teeth pocket probe depth ( PD ) ≥ 5mm least 2 different quadrant Control group design healthy fullmouth probe depth ( PD ) ≤3mm bleed probing ( BOP ) score &lt; % 15 examination radiographic evidence alveolar bone loss . Presence systemic disorder could influence course periodontal disease ; pregnancy , lactation , current former use tobacco ; Administration nonsteroidal antiinflammatory drug antibiotic therapy within previous 6 month ; Need antibiotic prophylaxis dental treatment receive nonsurgical periodontal treatment within past 6 month surgical periodontal treatment within past 12 month . Subjects body mass index ( BMI ) &gt; 24.9 kg /m2</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>periodontitis</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>chemerin</keyword>
	<keyword>interleukin-6</keyword>
</DOC>